Cargando…

Management and Treatment of Myocarditis in Athletes

PURPOSE OF REVIEW: Myocarditis is an inflammation of the myocardium that can often be associated with cardiac dysfunction and arrhythmias, and is even one of the leading causes for sudden cardiac death (SCD) in athletes. This review aims to summarize the current evidence and treatment guidelines for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurwitz, Benjamin, Issa, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609375/
https://www.ncbi.nlm.nih.gov/pubmed/33169059
http://dx.doi.org/10.1007/s11936-020-00875-1
_version_ 1783605019479638016
author Hurwitz, Benjamin
Issa, Omar
author_facet Hurwitz, Benjamin
Issa, Omar
author_sort Hurwitz, Benjamin
collection PubMed
description PURPOSE OF REVIEW: Myocarditis is an inflammation of the myocardium that can often be associated with cardiac dysfunction and arrhythmias, and is even one of the leading causes for sudden cardiac death (SCD) in athletes. This review aims to summarize the current evidence and treatment guidelines for the management of myocarditis in the active population. RECENT FINDINGS: Physical exertion is likely a trigger for dangerous arrythmias and further propagates myocardial damage in athletes with myocarditis. For this reason, abstinence from sports is a critical facet of management in the initial inflammatory period. The use of cardiac magnetic resonance imaging, specifically late gadolinium enhancement, to guide return to play decisions is becoming more common in clinical practice. SUMMARY: Establishing a stepwise approach for proper diagnosis and risk stratification, with an emphasis on contemporary cardiac magnetic resonance (CMR) imaging techniques, in myocarditis is critical. After a diagnosis of myocarditis is made, it is imperative for any athlete or highly active individual to refrain from physical exercise. Additionally, therapy for heart failure should be applied in cases of myocarditis with cardiac dysfunction. Undoubtedly, COVID 19, and its potential to cause myocarditis, is sure to change the landscape of management of this disease.
format Online
Article
Text
id pubmed-7609375
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-76093752020-11-05 Management and Treatment of Myocarditis in Athletes Hurwitz, Benjamin Issa, Omar Curr Treat Options Cardiovasc Med Sports Cardiology (M Wasfy, Section Editor) PURPOSE OF REVIEW: Myocarditis is an inflammation of the myocardium that can often be associated with cardiac dysfunction and arrhythmias, and is even one of the leading causes for sudden cardiac death (SCD) in athletes. This review aims to summarize the current evidence and treatment guidelines for the management of myocarditis in the active population. RECENT FINDINGS: Physical exertion is likely a trigger for dangerous arrythmias and further propagates myocardial damage in athletes with myocarditis. For this reason, abstinence from sports is a critical facet of management in the initial inflammatory period. The use of cardiac magnetic resonance imaging, specifically late gadolinium enhancement, to guide return to play decisions is becoming more common in clinical practice. SUMMARY: Establishing a stepwise approach for proper diagnosis and risk stratification, with an emphasis on contemporary cardiac magnetic resonance (CMR) imaging techniques, in myocarditis is critical. After a diagnosis of myocarditis is made, it is imperative for any athlete or highly active individual to refrain from physical exercise. Additionally, therapy for heart failure should be applied in cases of myocarditis with cardiac dysfunction. Undoubtedly, COVID 19, and its potential to cause myocarditis, is sure to change the landscape of management of this disease. Springer US 2020-11-04 2020 /pmc/articles/PMC7609375/ /pubmed/33169059 http://dx.doi.org/10.1007/s11936-020-00875-1 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Sports Cardiology (M Wasfy, Section Editor)
Hurwitz, Benjamin
Issa, Omar
Management and Treatment of Myocarditis in Athletes
title Management and Treatment of Myocarditis in Athletes
title_full Management and Treatment of Myocarditis in Athletes
title_fullStr Management and Treatment of Myocarditis in Athletes
title_full_unstemmed Management and Treatment of Myocarditis in Athletes
title_short Management and Treatment of Myocarditis in Athletes
title_sort management and treatment of myocarditis in athletes
topic Sports Cardiology (M Wasfy, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609375/
https://www.ncbi.nlm.nih.gov/pubmed/33169059
http://dx.doi.org/10.1007/s11936-020-00875-1
work_keys_str_mv AT hurwitzbenjamin managementandtreatmentofmyocarditisinathletes
AT issaomar managementandtreatmentofmyocarditisinathletes